ED: The clock is ticking

Vaccination remains the most viable solution out of this pandemic

It is alarming to learn that, assuming our vaccination rollout continues at the same pace as it has, the stock for the Covishield, the Oxford-AstraZeneca Covid-19 vaccine manufactured by Serum Institute of India, will run out within 10 days.

However, there may be some hope, as there is talk of Bangladesh receiving the Chinese Sinopharm vaccine doses from China before Eid, while Bangladesh is also eyeing possible procurement from Russia for the Sputnik V vaccine.